Elicio Therapeutics, Inc. Deferred Tax Assets, Tax Deferred Expense, Other
Elicio Therapeutics, Inc. (ELTX) had Deferred Tax Assets, Tax Deferred Expense, Other of $149.00 thousand as of 2022-12-31, per its 10-K filed 2023-03-17.
Discontinued › Notes › Income Taxes › Deferred Tax Assets, Gross › Deferred Tax Assets, Tax Deferred Expense
us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther · last filed 2023-03-17
- 2022-12-31: Deferred Tax Assets, Tax Deferred Expense, Other $149.00K.
- 2021-12-31: Deferred Tax Assets, Tax Deferred Expense, Other $536.00K.
- 2020-12-31: Deferred Tax Assets, Tax Deferred Expense, Other $658.00K.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Other |
|---|---|
| 2022-12-31 | $149.00K 10-K · filed 2023-03-17 |
| 2021-12-31 | $536.00K 10-K · filed 2023-03-17 |
| 2020-12-31 | $658.00K 10-K · filed 2022-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |